| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.5M | +130.3% |
| Cost of Revenue | $3.3M | +133.6% |
| Gross Profit | $170K | +80.9% |
| R&D Expense | $42.5M | +14.8% |
| SG&A Expense | $22.8M | -6.7% |
| Operating Income | -$65.6M | -2.0% |
| Income Tax | $0 | — |
| Net Income | -$57.2M | -9.9% |
| EPS (Basic) | -$0.33 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.9M | +148.6% |
| Short-term Investments | $69.4M | -37.4% |
| Accounts Receivable | $489K | -74.6% |
| Current Assets | $98.6M | -24.7% |
| Total Assets | $203.6M | -22.6% |
| Current Liabilities | $9.9M | -31.0% |
| Total Liabilities | $11.6M | -38.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.5M | +18.0% |
| Capital Expenditures | $23.7M | +43.7% |
| Investing Cash Flow | $60.9M | +2.4% |
| Financing Cash Flow | -$670K | +95.3% |
| Free Cash Flow | -$70.3M | +4.1% |
| -10.0% |
| EPS (Diluted) | -$0.33 | -10.0% |
| Stockholders' Equity |
| $192.0M |
| -21.4% |